Brainomix partners with Boehringer Ingelheim to utilize AI imaging software for fibrosing lung disease patients in the US.

Brainomix partners with Boehringer Ingelheim to improve care for fibrosing lung disease patients in the US. The collaboration will focus on utilizing Brainomix's e-Lung AI imaging software to analyze CT scans, accelerating diagnosis and improving treatment access for progressive pulmonary fibrosis patients. This chronic, life-limiting condition can significantly reduce patients' lifespans if left untreated.

July 18, 2024
3 Articles

Further Reading